{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:15:23Z","timestamp":1792145723502,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST110-2320-038-035-MY3"],"award-info":[{"award-number":["MOST110-2320-038-035-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST109-2320-B-038-045-MY3"],"award-info":[{"award-number":["MOST109-2320-B-038-045-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B-038-041"],"award-info":[{"award-number":["NSTC112-2320-B-038-041"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2320-B-038-038"],"award-info":[{"award-number":["NSTC 114-2320-B-038-038"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"publisher","award":["111TMU-TMUH-02-2"],"award-info":[{"award-number":["111TMU-TMUH-02-2"]}],"id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"publisher","award":["110TMU-TMUH-01-2"],"award-info":[{"award-number":["110TMU-TMUH-01-2"]}],"id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejphar.2026.178824","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:35:05Z","timestamp":1774658105000},"page":"178824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injury"],"prefix":"10.1016","volume":"1021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-8494","authenticated-orcid":false,"given":"Ming-Jen","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsin","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-0245","authenticated-orcid":false,"given":"Jin-Cherng","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tur-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6276-1991","authenticated-orcid":false,"given":"Yu-Han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178824_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77934-x","article-title":"The antiplatelet agent revacept prevents the increase of systemic thromboxane A(2) biosynthesis and neointima hyperplasia","volume":"10","author":"Alberti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178824_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2026.178824_bib3","doi-asserted-by":"crossref","first-page":"10527","DOI":"10.1074\/jbc.275.14.10527","article-title":"Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase","volume":"275","author":"Bae","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178824_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.684920","article-title":"Soluble platelet release factors as biomarkers for cardiovascular disease","volume":"8","author":"Baidildinova","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.178824_bib5","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke Statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178824_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2016.08.015","article-title":"Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells","volume":"9","author":"Byon","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.178824_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.12472","article-title":"Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation","volume":"12","author":"Capra","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2026.178824_bib8","first-page":"166","article-title":"Redox regulation of platelet-derived-growth-factor-receptor: role of NADPH-oxidase and c-Src tyrosine kinase","volume":"1745","author":"Catarzi","year":"2005","journal-title":"Bba-Mol Cell Res"},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2026.178824_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000209262","article-title":"TP receptor antagonism: a new concept in atherothrombosis and stroke prevention","volume":"27","author":"Chamorro","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2026.178824_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2006.02.033","article-title":"Reactive oxygen species signaling in vascular smooth muscle cells","volume":"71","author":"Clempus","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178824_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1253\/circj.CJ-11-0366","article-title":"Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy","volume":"75","author":"Curcio","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ejphar.2026.178824_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2174\/138161206776055921","article-title":"From the design to the clinical application of thromboxane modulators","volume":"12","author":"Dogne","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.178824_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/ATVBAHA.121.317380","article-title":"A thromboxane A(2) receptor-driven COX-2-Dependent feedback loop that affects endothelial homeostasis and angiogenesis","volume":"42","author":"Eckenstaler","year":"2022","journal-title":"Arterioscl. Throm. Vas."},{"key":"10.1016\/j.ejphar.2026.178824_bib14","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/slct.201904832","article-title":"A review on the modern synthetic approach of benzimidazole candidate","volume":"5","author":"Faheem","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejphar.2026.178824_bib15","article-title":"Myricanol inhibits platelet derived growth Factor-BB-Induced vascular smooth muscle cells proliferation and migration in vitro and intimal hyperplasia in vivo by targeting the platelet-derived growth factor receptor-beta and NF-kappaB signaling","volume":"12","author":"Fan","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.178824_bib16","first-page":"85","article-title":"TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis","volume":"60","author":"Feletou","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib17","doi-asserted-by":"crossref","first-page":"18947","DOI":"10.1074\/jbc.M116.739722","article-title":"Thromboxane A2 activates YAP\/TAZ to induce vascular smooth muscle cell proliferation and migration","volume":"291","author":"Feng","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178824_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/ATVBAHA.118.312196","article-title":"Metabolic stress mitochondrial function in neointimal formation","volume":"39","author":"Grumbach","year":"2019","journal-title":"Arterioscl. Throm. Vas."},{"key":"10.1016\/j.ejphar.2026.178824_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862326","article-title":"Anti-angiogenetic and anti-lymphangiogenic effects of a novel 2-Aminobenzimidazole derivative, MFB","volume":"12","author":"Hsu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.178824_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/TH15-12-0993","article-title":"A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models","volume":"116","author":"Huang","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.178824_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/carcin\/bgs127","article-title":"Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling","volume":"33","author":"Huang","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2026.178824_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1160\/TH17-07-0519","article-title":"Inhibitory effects of an orally active thromboxane A2 receptor antagonist, nstpbp5185, on atherosclerosis in ApoE-Deficient mice","volume":"118","author":"Huang","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.178824_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2005.04.013","article-title":"Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA\/rho-associated kinase in rat vascular smooth muscle cells","volume":"515","author":"Ishikura","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00005344-200304000-00009","article-title":"Ramatroban, a thromboxane A2 receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbits","volume":"41","author":"Ishizuka","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vph.2009.11.001","article-title":"Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model","volume":"52","author":"Jandt","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib26","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/eurheartj\/ehs001","article-title":"Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis (Mini-COREA) trial: celecoxib, a double-edged sword for patients with angina","volume":"33","author":"Kang","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.178824_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI200421446","article-title":"Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice","volume":"114","author":"Kobayashi","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178824_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/ATVBAHA.112.300862","article-title":"Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury","volume":"33","author":"Kohno","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178824_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0885328216630498","article-title":"Prednisolone- and sirolimus-eluting stent: anti-inflammatory approach for inhibiting in-stent restenosis","volume":"31","author":"Lee","year":"2016","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejphar.2026.178824_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apsb.2022.09.010","article-title":"Benzimidazole and its derivatives as cancer therapeutics: the potential role from traditional to precision medicine","volume":"13","author":"Lee","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.178824_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2125.2010.03858.x","article-title":"Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis","volume":"71","author":"Lesault","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cardiores.2004.08.008","article-title":"PDGF receptor kinase inhibitors for the treatment of restenosis","volume":"65","author":"Levitzki","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178824_bib55","doi-asserted-by":"crossref","first-page":"514494","DOI":"10.3389\/fphys.2020.514494","article-title":"Osthole Alleviates Neointimal Hyperplasia in Balloon-Induced Arterial Wall Injury by Suppressing Vascular Smooth Muscle Cell Proliferation and Downregulating Cyclin D1\/CDK4 and Cyclin E1\/CDK2 Expression","volume":"11","author":"Li","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.ejphar.2026.178824_bib33","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1111\/bph.14813","article-title":"A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling","volume":"176","author":"Lien","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1538-7836.2003.00533.x","article-title":"Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)","volume":"2","author":"Lijnen","year":"2004","journal-title":"J. Thromb Haemost."},{"key":"10.1016\/j.ejphar.2026.178824_bib34","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/jth.13799","article-title":"ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation","volume":"15","author":"Lu","year":"2017","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2026.178824_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jjcc.2018.03.001","article-title":"Dual antiplatelet therapy after coronary stent implantation: individualizing the optimal duration","volume":"72","author":"Lugo","year":"2018","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178824_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","article-title":"Vascular smooth muscle cell proliferation in restenosis","volume":"4","author":"Marx","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2026.178824_bib53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjp.0705087","article-title":"The ACh-induced contraction in rat aortas is mediated by the Cys Lt(1) receptor via intracellular calcium mobilization in smooth muscle cells","volume":"138","author":"Mazzetti","year":"2003","journal-title":"Brit J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178824_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41440-018-0162-x","article-title":"Diverse associations between oxidative stress and thromboxane A(2) in hypertensive glomerular injury","volume":"42","author":"Nakano","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.178824_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2026.178824_bib39","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"4","author":"Percie du Sert","year":"2020","journal-title":"BMJ Open Sci"},{"key":"10.1016\/j.ejphar.2026.178824_bib40","series-title":"Physiology, Thromboxane A2","author":"Rucker","year":"2025"},{"key":"10.1016\/j.ejphar.2026.178824_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2020.06.066","article-title":"Duration of dual antiplatelet therapy after percutaneous coronary intervention for chronic total occlusion","volume":"132","author":"Sachdeva","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178824_bib42","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1161\/01.CIR.92.11.3194","article-title":"Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. multi-hospital eastern Atlantic restenosis trial (M-HEART II)","volume":"92","author":"Savage","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178824_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.77.2.361","article-title":"Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months","volume":"77","author":"Serruys","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178824_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178824_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/hq0102.102189","article-title":"Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury","volume":"22","author":"Szocs","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178824_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0002-8703(98)70230-3","article-title":"Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result","volume":"136","author":"van 't Hof","year":"1998","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.178824_bib46","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1152\/ajprenal.00371.2013","article-title":"Src tyrosine kinase mediates platelet-derived growth factor BB-induced and redox-dependent migration in metanephric mesenchymal cells","volume":"306","author":"Wagner","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2026.178824_bib47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.RES.0000126848.54740.4A","article-title":"Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration","volume":"94","author":"Weber","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.178824_bib48","volume":"vol. 73","author":"Worlein","year":"2011"},{"key":"10.1016\/j.ejphar.2026.178824_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102586","article-title":"MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription","volume":"59","author":"Wu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.178824_bib50","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/01.ATV.0000144009.35400.65","article-title":"Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta","volume":"24","author":"Yamaguchi","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178824_bib51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1179\/1743132812Y.0000000022","article-title":"Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials","volume":"34","author":"Zhang","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2026.178824_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:59:45Z","timestamp":1777402785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"alternative-id":["S0014299926003067"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178824","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178824"}}